<i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways - Concepedia

Concepedia

Publication | Open Access

<i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways

DOI Full Paper Access

21

Citations

31

References

2023

Year

Subhamoy Chakraborty, Charles Coleman, Parvathy Manoj, Deniz Demircioğlu, Nisargbhai Shah, Elisa de Stanchina, Charles M. Rudin, Dan Hasson, Triparna Sen

Clinical Cancer Research

Abstract

Our study provides a mechanistic insight into lurbinectedin response in SCLC and the first demonstration that lurbinectedin is a potential therapeutic target after SCLC transformation.

References

	Year	Citations

Page 1